Sowell Financial Services LLC United Therapeutics Corp Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$170.47 - $211.93 $55,061 - $68,453	-323 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$153.94 - $174.85 $40,794 - $46,335	265 Added 456.9%	323 $62,000
Q4 2020 Jan 13, 2021	SELL	$101.87 - $151.79 $101 - $151	-1 Reduced 1.69%	58 $9,000
Q3 2020 Nov 12, 2020	SELL	$99.9 - $121.13 $4,995 - $6,056	-50 Reduced 45.87%	59 $6,000
Q2 2020 Aug 13, 2020	SELL	$92.74 - $125.82 $26,430 - $35,858	-285 Reduced 72.34%	109 $13,000
Q1 2020 May 12, 2020	SELL	$79.39 - $115.35 $26,833 - $38,988	-338 Reduced 46.17%	394 $37,000
Q4 2019 Feb 07, 2020	BUY	$78.31 - $95.34 $34,299 - $41,758	438 Added 148.98%	732 $64,000
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $22,005 - $25,281	294 New	294 $23,000

672

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.